49.64 USD
▲+0.32+2.65%
盘后 48.48 +0.25%
2026-08-03
市值
$3.53B
市盈率
—
EPS
-2.71
股息率
—
52 周区间
15.80 – 94.90
成交量
876.74K
Beta
-1.51
目标价
104.83
52W 低 15.8052W 高 94.90
价格走势
公司简介
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671 and ACCG-3535, an oral small molecule amylin receptor agonist that...